Clinical Trial Update: Efficacy, Safety and Tolerability of Propionyl-L-Carnitine Hydrochloride in Patients With Mild Ulcerative Colitis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating Propionyl-L-Carnitine Hydrochloride in patients with mild ulcerative colitis was terminated; no final efficacy or safety results are re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Propionyl-L-Carnitine Hydrochloride (Propionyl-L-carnitine hydrochloride)

Snippet

Sponsor: sigma-tau i.f.r. S.p.A. | Conditions: Ulcerative Colitis | Phase 3 | Status: TERMINATED